ELPIDA Trademark

Trademark Overview

On Tuesday, December 12, 2017, a trademark application was filed for ELPIDA with the United States Patent and Trademark Office. The USPTO has given the ELPIDA trademark a serial number of 87717506. The federal status of this trademark filing is REGISTERED as of Tuesday, December 31, 2019. This trademark is owned by Viriom, Inc.. The ELPIDA trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical and veterinary drugs for treatment of infectious viral diseases, including Acquired Immune Deficiency Syndrome (AIDS) caused by the Human Immunodeficiency Virus (HIV)
elpida

General Information

Serial Number87717506
Word MarkELPIDA
Filing DateTuesday, December 12, 2017
Status700 - REGISTERED
Status DateTuesday, December 31, 2019
Registration Number5950711
Registration DateTuesday, December 31, 2019
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, May 22, 2018

Trademark Statements

Goods and ServicesPharmaceutical and veterinary drugs for treatment of infectious viral diseases, including Acquired Immune Deficiency Syndrome (AIDS) caused by the Human Immunodeficiency Virus (HIV)

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateThursday, December 21, 2017
Primary Code005
First Use Anywhere DateTuesday, October 20, 2015
First Use In Commerce DateThursday, February 16, 2017

Trademark Owner History

Party NameViriom, Inc.
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressSan Diego, CA 92130
Party NameViriom, Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressSan Diego, CA 92130
Party NameViriom, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressSan Diego, CA 92121

Trademark Events

Event DateEvent Description
Monday, October 9, 2023TEAS CHANGE OF CORRESPONDENCE RECEIVED
Monday, October 9, 2023ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Monday, October 9, 2023TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Tuesday, December 31, 2019REGISTERED-PRINCIPAL REGISTER
Wednesday, November 27, 2019NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
Tuesday, November 26, 2019ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Thursday, November 21, 2019STATEMENT OF USE PROCESSING COMPLETE
Tuesday, November 12, 2019USE AMENDMENT FILED
Thursday, November 21, 2019CASE ASSIGNED TO INTENT TO USE PARALEGAL
Tuesday, November 12, 2019TEAS STATEMENT OF USE RECEIVED
Tuesday, May 14, 2019NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, April 2, 2019TTAB RELEASE CASE TO TRADEMARKS
Tuesday, April 2, 2019OPPOSITION TERMINATED NO. 999999
Tuesday, April 2, 2019OPPOSITION DISMISSED NO. 999999
Friday, November 16, 2018OPPOSITION INSTITUTED NO. 999999
Monday, June 25, 2018TEAS CHANGE OF CORRESPONDENCE RECEIVED
Friday, June 15, 2018EXTENSION OF TIME TO OPPOSE RECEIVED
Wednesday, May 23, 2018APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Wednesday, May 23, 2018TEAS CHANGE OF OWNER ADDRESS RECEIVED
Tuesday, May 22, 2018OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, May 22, 2018PUBLISHED FOR OPPOSITION
Wednesday, May 2, 2018NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Thursday, April 12, 2018APPROVED FOR PUB - PRINCIPAL REGISTER
Thursday, April 12, 2018EXAMINER'S AMENDMENT ENTERED
Thursday, April 12, 2018NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Thursday, April 12, 2018EXAMINERS AMENDMENT E-MAILED
Thursday, April 12, 2018EXAMINERS AMENDMENT -WRITTEN
Monday, March 26, 2018NOTIFICATION OF NON-FINAL ACTION E-MAILED
Monday, March 26, 2018NON-FINAL ACTION E-MAILED
Monday, March 26, 2018NON-FINAL ACTION WRITTEN
Thursday, March 22, 2018ASSIGNED TO EXAMINER
Thursday, December 21, 2017NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Friday, December 15, 2017NEW APPLICATION ENTERED

Related Keywords

elpida aids syndrome deficiency caused human virus immunodeficiency immune acquired treatment